Archive: 01/30/2013
Silibinin, found in milk thistle, protects against UV-induced skin cancer
A pair of University of Colorado Cancer Center studies published this month show that the milk thistle extract, silibinin, kills skin cells mutated by UVA radiation and protects against damage by UVB radiation – thus protecting ...
Cancer
Jan 30, 2013 |
4 / 5 (2) |
0
|
Family practice offers genetic tests to predict effective psychiatric meds
For the first time in Canada, patients attending a family practice clinic will be offered genetic testing to see whether or how they will respond to psychiatric medication treatment, in partnership with the Centre for Addiction ...
Psychology & Psychiatry
Jan 30, 2013 |
not rated yet |
0
Moxifloxacin monotherapy equivalent to antibiotic combo
(HealthDay)—Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer ...
Cancer
Jan 30, 2013 |
not rated yet |
0
Drug OK'd for deadly genetic condition tied to cholesterol
(HealthDay)—Kynamro (mipomersen sodium) has been approved by the U.S. Food and Drug Administration to treat a rare inherited condition in which the body can't remove low-density lipoprotein (LDL) cholesterol from the blood.
Medications
Jan 30, 2013 |
not rated yet |
0
EPA moves to ban some rodent poisons
(AP)—The Environmental Protection Agency is moving to ban the sale of a dozen rat and mouse poisons sold under the popular D-Con brand in an effort to protect children and pets.
Health
Jan 30, 2013 |
not rated yet |
0
Study identifies biomarker and potential therapy target in multiple sclerosis
Researchers from Benaroya Research Institute at Virginia Mason (BRI) have found that proteins in the IL-6 signaling pathway may be leveraged as novel biomarkers of multiple sclerosis (MS) to gauge disease activity and as ...
Immunology
Jan 30, 2013 |
5 / 5 (1) |
0
|
Tuberculosis may lurk in bone marrow stem cells of infected patients, researchers say
Tuberculosis is a devastating disease that kills nearly 2 million people worldwide each year. Although antibiotics exist that can ameliorate the symptoms, the courses of therapy last for months and don't completely eradicate ...
Medical research
Jan 30, 2013 |
5 / 5 (2) |
0
|
Itching for new help for eczema: Recently identified immune cells possible therapeutic target
Researchers have identified a previously unknown critical role for a recently identified immune cell population in the progression of atopic dermatitis. The team found an accumulation of innate lymphoid cells ...
Immunology
Jan 30, 2013 |
5 / 5 (1) |
0
|
Scientists gain new understanding of latent tuberculosis
Scientists at the Forsyth have gained new insight on how Tuberculosis (TB) remains a global epidemic. Although drugs have been available to fight TB for 50 years, the disease still infects nearly 2.2 billion people worldwide ...
Diseases, Conditions, Syndromes
Jan 30, 2013 |
not rated yet |
0
Peer pressure trumps 'thin' ideals in the media
Peers exert a greater influence on teenage girls' dissatisfaction with their bodies than do thin ideals in television or social media use, according to new research by Dr. Christopher J. Ferguson and colleagues from Texas ...
Health
Jan 30, 2013 |
5 / 5 (1) |
0
Are gender and ethnicity risk factors for metabolic syndrome in children?
Metabolic syndrome is more likely to affect children who are obese than overweight or non-overweight and who have other characteristics associated with the disorder, such as high blood pressure or insulin ...
Diseases, Conditions, Syndromes
Jan 30, 2013 |
not rated yet |
0
Researchers improve medical units to reduce nursing fatigue, cut costs
In hospitals, poor floor design, storage closet clutter and crowded corridors can contribute to nurse and medical staff fatigue. These distractions can hurt patient care quality and result in higher medical costs.
Health
Jan 30, 2013 |
not rated yet |
0
How does fibrosis occur in Crohn's disease?
New research has shown that a protein, known as IL-13, could be the key to the development of fibrosis in Crohn's disease. This breakthrough could help to advance new medicines to treat people suffering with the disease.
Diseases, Conditions, Syndromes
Jan 30, 2013 |
not rated yet |
0
|
Mindfulness meditation heightens a listener's musical engagement
When De'Anthony Thomas returned the opening kickoff for a touchdown in the 2013 Fiesta Bowl, says University of Oregon researcher Frank Diaz, Thomas put Ducks fans into a heightened zone of engagement for ...
Psychology & Psychiatry
Jan 30, 2013 |
5 / 5 (1) |
0
Researchers confirm value of flow-diverting device for most challenging aneurysms
A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that ...
Neuroscience
Jan 30, 2013 |
not rated yet |
0
